Developer of late-stage preclinical drugs designed for oral therapy for obesity, diabetes, and rare diseases.
| Date | Amount | Stage | Investors |
|---|---|---|---|
Clients Only Feature
Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.
|
Home 
My News 
Companies 
Acquisitions 
Technology 
Job Openings